Effects of nebulized corticosteroids therapy on hypothalamic-pituitary- adrenal axis in young children with recurrent or persistent wheeze

Pediatric Allergy and Immunology

Volumn 19, Issue 8, 2008, Pages 773-776

  Cetinkaya, Feyzullah ^a,c   Kayiran, Petek ^a   Memioglu, Nihal ^a   Tarim, Omer Faruk ^b   Eren, Nezaket ^a   Erdem, Ela ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Asthma; Budesonide; Corticosteroids; Fluticasone propionate; Hypothalamic pituitary adrenal

Indexed keywords

BUDESONIDE; CORTICOTROPIN; FLUTICASONE PROPIONATE; HEMOGLOBIN A1C; TETRACOSACTIDE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ELECTROLYTE BLOOD LEVEL; ENDOCRINE FUNCTION TEST; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFANT; LONG TERM CARE; MALE; MEDICAL NEBULIZER; NEBULIZATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; WHEEZING;

ADMINISTRATION, INHALATION; ADRENOCORTICOTROPIC HORMONE; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD, PRESCHOOL; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFANT; MALE; NEBULIZERS AND VAPORIZERS; PITUITARY-ADRENAL SYSTEM; RECURRENCE; RESPIRATORY SOUNDS;

EID: 56649105256     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2008.00716.x     Document Type: Article

References (25)

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention Revised (2002). NHLBI/WHO Workshop Report. Bethesda, MD : National Institutes of Health, National Heart, Lung, and Blood Institute, 2002. NIH publication No. 02 : 36 59.
2. National Institutes of Health, National Heart, Lung, and Blood Institute. National asthma education and prevention programme. Expert panel report: guidelines for the diagnosis and management of asthma update on selected topics 2002. J Allergy Clin Immunol 2002 : 110 : S142 219.
3. Verberne AA, Frost C, Duiverman EJ, Grol MH, Kerrebijn KF. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. Am J Respir Crit Care Med 1998 : 158 : 213 9.
4. Berger WE, Qaqundah PY, Blake K, et al. Safety of budesonide inhalation suspension in infants aged six to twelve months with mild to moderate persistent asthma or recurrent wheeze. J Pediatr 2005 : 146 : 91 95.
5. Weinberger M. Inhaled corticosteroids for infants. J Pediatr 2006 : 148 : 284.
6. Speckart PF, Nicholoff JT, Bethune JE. 1971 Screening for adrenocortical insufficiency with cosyntropin (synthetic ACTH). Arch Intern Med 1971 : 128 : 761 3.
7. Aron DC, Blake-Tyrrel J. Glucocorticoid & adrenal androgens. In : Greenspan FS, Baxter JD edn 4, eds. Basic and Clinical Endocrinology. Norwalk, CT : Appleton & Langhman, 1994 : 307 46.
8. Grinspoon SK, Biller BMK. Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 1994 : 79 : 923 31.
9. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 1999 : 159 : 941 55.
10. Toogood JH. Side effects of inhaled corticosteroids. J Allergy Clin Immunol 1998 : 102 : 705 13.
11. Pedersen S. State of the art: do inhaled corticosteroids inhibit growth in children? Am J Respir Crit Care Med 2001 : 164 : 521 35.
12. Macdessi JS, Randell TL, Donaghue KC, Ambler GR, van Asperen PP, Mellis CM. Adrenal crises in children treated with high-dose inhaled corticosteroids for asthma. Med J Aust 2003 : 178 : 214 6.
13. Drake AJ, Howells RJ, Shield JP, Prendiville A, Ward PS, Crowne EC. Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate. BMJ 2002 : 324 : 1081 2.
14. Patel L, Wales JK, Kibirige MS, Massarano AA, Couriel JM, Clayton PE. Symptomatic adrenal insufficiency during inhaled corticosteroid treatment. Arch Dis Child 2001 : 85 : 330 4.
15. Priftis KN, Papadimitriou A, Gatsopoulou E, Yiallouros PK, Fretzayas A, Nicolaidou P. The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children. Eur Respir J 2006 : 27 : 316 20.
16. Smaldone GC, Cruz-Rivera M, Nikander K. In vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspension. J Aerosol Med 1998 : 11 : 113 25.
17. Agertoft L, Andersen A, Weibull E, Pedersen S. Systemic availability and pharmacokinetics of nebulized budesonide in preschool children. Arch Dis Child 1999 : 80 : 241 7.
18. Szefler SJ. Pharmacodynamics and pharmacokinetics of budesonide: a new nebulized corticosteroid: a new nebulized corticosteroid. J Allergy Clin Immunol 1999 : 104 : S175 83.
19. Carlsen KC, Stick S, Kamin W, Cirule I, Hughes S, Wixon C. The efficacy and safety of fluticasone propionate in very young children with persistent asthma symptoms. Respir Med 2005 : 99 : 1393 402.
20. Kannisto S, Korppi M, Remes K, Voutilainen R. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. J Clin Endocrinol Metabol 2000 : 85 : 652 7.
21. Dickstein G, Shechner C, Nicholson WE, et al. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab 1991 : 72 : 773 8.
22. Abdu TA, Elhadd TA, Neary R, Clayton RN. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab 1999 : 84 : 838 43.
23. Mayenknecht J, Diederich S, Bahr V, Plockinger U, Oelkers W. Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endocrinol Metab 1998 : 83 : 1558 62.
24. Gonzalez-Gonzalez JG, De la Garza-Hernandez NE, Mancillas-Adame LG, Montes-Villarreal J, Villarreal-Perez JZ. A high-sensitivity test in the assessment of adrenocortical insufficiency: 10 microg vs 250 microg cosyntropin dose assessment of adrenocortical insufficiency. J Endocrinol 1998 : 159 : 275 80.
25. Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma. Arch Dis Child 1993 : 69 : 206 11.